Overview

A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
Phase:
Phase 2
Details
Lead Sponsor:
Anderson Clinical Research
Collaborator:
Ligand Pharmaceuticals
Treatments:
Alitretinoin